1-1 of 1
Robert Kerr, MD
Close
Sort by
Journal Articles

A Phase II Study of Denileukin Diftitox (ONTAK R ) in Patients with Fludarabine Refractory B-Cell Chronic Lymphocytic Leukemia.

Philip Kuriakose, MD, Francesco Turturro, MD, Jesus G. Berdeja, MD, Robert Kerr, MD, Asha Surendranathan, Jennifer Black, Arthur E. Frankel, MD
Journal: Blood
Blood (2004) 104 (11): 4824.
https://doi.org/10.1182/blood.V104.11.4824.4824
Published: 2004